BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 17240501)

  • 41. [Forensic psychiatric expert evaluation of so-called drug-induced psychoses].
    Hollweg M; Soyka M; Nedopil N
    Psychiatr Prax; 1995 Sep; 22(5):197-200. PubMed ID: 7480371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of smokers with a psychotic disorder and implications for smoking interventions.
    Baker A; Richmond R; Haile M; Lewin TJ; Carr VJ; Taylor RL; Constable PM; Jansons S; Wilhelm K; Moeller-Saxone K
    Psychiatry Res; 2007 Mar; 150(2):141-52. PubMed ID: 17289155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Models of co-occurring substance misuse and psychosis: are personality traits the missing link?
    Hides L; Lubman DI; Dawe S
    Drug Alcohol Rev; 2004 Dec; 23(4):425-32. PubMed ID: 15763747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual diagnosis: a review of etiological theories.
    Mueser KT; Drake RE; Wallach MA
    Addict Behav; 1998; 23(6):717-34. PubMed ID: 9801712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thought, feeling, and action in real time--monitoring of drug use in schizophrenia.
    Csernansky JG; Smith MJ
    Am J Psychiatry; 2011 Feb; 168(2):120-2. PubMed ID: 21297046
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug abuse: a significant variable in schizophrenia research.
    Boutros N; Bonnet K; Mak T
    Biol Psychiatry; 1996 Jun; 39(12):1053-4. PubMed ID: 8780842
    [No Abstract]   [Full Text] [Related]  

  • 49. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders.
    Dekker N; Linszen DH; De Haan L
    Psychopathology; 2009; 42(6):350-60. PubMed ID: 19752588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The coherence of the evidence linking cannabis with psychosis.
    Henquet C; Van Os J
    Psychol Med; 2008 Mar; 38(3):461-2; author reply 462-4. PubMed ID: 18298878
    [No Abstract]   [Full Text] [Related]  

  • 52. [Psychosis and substance abuse].
    Vaz Carneiro S; Borrego M
    Acta Med Port; 2007; 20(5):413-22. PubMed ID: 18282438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia.
    Swendsen J; Ben-Zeev D; Granholm E
    Am J Psychiatry; 2011 Feb; 168(2):202-9. PubMed ID: 21078705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases.
    Niemi-Pynttäri JA; Sund R; Putkonen H; Vorma H; Wahlbeck K; Pirkola SP
    J Clin Psychiatry; 2013 Jan; 74(1):e94-9. PubMed ID: 23419236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.
    Schaub M; Fanghaenel K; Stohler R
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1060-5. PubMed ID: 19016094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort.
    Stirling J; Barkus EJ; Nabosi L; Irshad S; Roemer G; Schreudergoidheijt B; Lewis S
    Psychopathology; 2008; 41(6):371-8. PubMed ID: 18787359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risky use and misuse of alcohol, drugs and cigarettes detected by screening questionnaires in a clinical psychosis unit.
    Cruce G; Nordström LG; Ojehagen A
    Nord J Psychiatry; 2007; 61(2):92-9. PubMed ID: 17454723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychiatric aspects of cannabis use in adolescents and young adults.
    Tunving K
    Pediatrician; 1987; 14(1-2):83-91. PubMed ID: 3497393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.